AKR1B1 was identified as a core gene for the regulation of the immune microenvironment, a biomarker for prognosis, and a potential target for gastric cancer treatment based on weighted gene co-expression network analysis, and data from The Cancer Genome Atlas-stomach adenocarcinoma and GSE62254 [107]. This evidence concerns the gene AKR1B1 and gastric cancer.